Journal article

Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT)


Authors listWagenlehner, Florian; Wullt, Bjorn; Ballarini, Stefania; Zingg, Daniel; Naber, Kurt G.

Publication year2018

Pages107-117

JournalExpert Review of Pharmacoeconomics & Outcomes Research

Volume number18

Issue number1

ISSN1473-7167

eISSN1744-8379

DOI Linkhttps://doi.org/10.1080/14737167.2017.1359543

PublisherTaylor and Francis Group


Abstract

Background: Uncomplicated lower urinary tract infections (UTIs) occur in approximately 50% of women, and 20-30% experience recurrent UTI. Data on UTIs and quality of life (QoL) in Europe are limited.

Methods: This was an anonymous, self-administered web-based survey conducted in 5 countries (Germany, Switzerland, Poland, Russia and Italy), on adult women who had experienced recurrent UTI and were affected by acute UTI currently or within 4 weeks of study entry. Questions covered disease course; management; social and economic burden; education, income, and health insurance status. QoL was evaluated using the SF-12v2.

Results: Participants reported a mean of 5.15 UTI symptoms, ranging from 4.85 - 5.38 in Russia and Germany. There was a mean of 2.78 doctor visits per year (1.74 - 3.71 in Russia and Germany; p < 0.0001). 80.3% of participants had been treated with antibiotics, mean prescriptions ranged from 2.17 (Poland) to 3.36 (Germany) per person per year. A mean of 3.09 days sick leave due to UTIs, and 3.45 days of limited activities, were reported. Although 73.8% of participants had tried prophylaxis recurrence was common and associated with mental stress for a high proportion of women.

Conclusions: Our results indicate that recurrent UTIs have a significant impact on QoL of women in Europe.




Citation Styles

Harvard Citation styleWagenlehner, F., Wullt, B., Ballarini, S., Zingg, D. and Naber, K. (2018) Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT), Expert review of pharmacoeconomics & outcomes research, 18(1), pp. 107-117. https://doi.org/10.1080/14737167.2017.1359543

APA Citation styleWagenlehner, F., Wullt, B., Ballarini, S., Zingg, D., & Naber, K. (2018). Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT). Expert review of pharmacoeconomics & outcomes research. 18(1), 107-117. https://doi.org/10.1080/14737167.2017.1359543



Keywords


ASCORBIC-ACIDDisease burdenDOUBLE-BLINDECONOMIC BURDENMental healthOM-89ORAL IMMUNOTHERAPYPROPHYLACTIC AGENTrecurrent urinary tract infectionsVAGINAL MUCOSAL VACCINEWOMEN

Last updated on 2025-21-05 at 18:27